Imagin Medical Inc. reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (“Lighthouse”). The Company is on target to demonstrate the i/Blue Imaging System™ in private meetings during the American Urology Association (AUA) meeting to be held in early September. The product will showcase updates to meet performance criteria against competitive products and improvements made to the design for manufacturing The updated product design also incorporates changes intended to meet critical verification requirements established through benchmark testing of competitive systems and feedback from preliminary meetings with the FDA. Additional testing and specification development has been focused on contrast-agent-induced fluorescence and the ability to replicate clinical observations in a bench-level study. Sensitivity of the system can now be fully demonstrated with the test methods that have been established.